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Background: Epithelial invagination is important for initiation of ectodermal organogenesis. Although many factors
regulate ectodermal organogenesis, there is not any report about their functions in real-time study. Electric
cell-substrate impedance sensing (ECIS), a non-invasive, real-time surveillance system, had been used to detect
changes in organ cell layer thickness through quantitative monitoring of the impedance of a cell-to-microelectrode
interface over time. It was shown to be a good method for identifying significant real-time changes of cells. The
purpose of this study is to establish a combined bioengineered organ-ECIS model for investigating the real time
effects of fibroblast growth factor-9 (FGF-9) on epithelial invagination in bioengineered ectodermal organs. We
dissected epithelial and mesenchymal cells from stage E14.5 murine molar tooth germs and identified the real-time
effects of FGF-9 on epithelial-mesenchymal interactions using this combined bioengineered organ-ECIS model.
Results: Measurement of bioengineered ectodermal organ thickness showed that Fibroblast growth factor-9
(FGF-9) accelerates epithelial invagination in reaggregated mesenchymal cell layer within 3 days. Gene expression
analysis revealed that FGF-9 stimulates and sustains early Ameloblastin and Amelogenin expression during
odontogenesis.
Conclusions: This is the first real-time study to show that, FGF-9 plays an important role in epithelial invagination
and initiates ectodermal organogenesis. Based on these findings, we suggest FGF-9 can be applied for further study
in ectodermal organ regeneration, and we also proposed that the ‘FGF-BMP balancing system’ is important for
manipulating the morphogenesis of ectodermal organs. The combined bioengineered organ-ECIS model is a
promising method for ectodermal organ engineering and regeneration research.
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Ectodermal organogenesis involves the development of
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teeth, beaks, nails, horns and several eccrine glands.
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reproduction in any medium, provided the orenchymal (mesodermal or neural crest) tissues, the first
visible sign of most ectodermal organs is a local epithe-
lial thickening termed an ectodermal placode. Next, a
condensation of mesenchymal cells, or papilla, forms
under the placode. The ectodermal placode then buds
into or out of the papilla in a process called epithelial in-
vagination. Subsequent morphogenesis drives further
development of the epithelial and mesenchymal compo-
nents and is associated with epithelial folding and
branching. This ultimately determines the final shape
and size of ectodermal organs; however, it is epithelial
invagination that regulates when and how ectodermal
organs develop, a fact with important implications forThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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see [1]].
Although many factors regulate ectodermal organogen-
esis, observing their functions in real-time is difficult. The
complex developmental progress at different time points
involves sophisticated spatial and temporal regulation of
growth factor superfamilies including the Bone morpho-
genetic protein (BMP), Fibroblast growth factor (FGF),
Tumour necrosis factor (TNF), Sonic hedgehog (Shh) and
Wnt superfamilies [for review see [2-4]]. Hence, future study
requires a more accurate model. The multipotency of em-
bryonic stem cells makes creation of a non-invasive, non-
inductive environment for the observation of specific growth
factor functions within ectodermal organ development chal-
lenging. Ectodermal organs are greatly affected by their
in vivo environment and its inherent regulating factors.
Bioengineered ectodermal organs can be developed
from murine molar tooth germs by dissociating the epi-
thelial and mesenchymal layers into single cells, then
reaggregating them into a new organ (regenerated tooth
germ). Previous studies have shown that these separated
cells, once reaggregated and with the correct compart-
ment relationship, can develop into complete, regener-
ated organs in vitro and in vivo [for review see [5-9]].
This bioengineered organ germ method [10] could facili-
tate regeneration of other ectodermal organs, even new
engineered organs, which could be transplanted and
function normally within humans [11]. However, be-
cause of the number of growth factors involved, methods
for manipulation of ectodermal organogenesis in vitro
and in vivo remain unelucidated.
Many growth factors are expressed during ectodermal or-
ganogenesis [12,13] and it is logical to study their specific
roles during organ regeneration. Studies have shown that
FGF-8 and FGF-9 are expressed within the murine molar
epithelium: FGF-8 has a specific role in multicuspid odonto-
genesis [13,14]; therefore, in this study, we investigated the
role of FGF-9, also present within the oral epithelium of the
first branchial arch at stage E10. FGF-9 expression is
restricted to the dental epithelium until epithelial budding at
E11. Although not expressed in the mesenchyme, FGF-9
appears in the cap-stage enamel knot of the E13–E15 mouse
embryo, spreading within the inner enamel epithelium until
E18 [14]. This suggests that FGF-9 is an important factor
during the initiation of tooth germ development. However,
tissue slicing and staining cannot provide a real-time model
for further investigation and, as FGF-9 is critical to embry-
onic development, a conventional transgenic approach could
cause early defects, or even embryonic demise, interfering
with in-depth study.
Electric cell-substrate impedance sensing (ECIS) is a
non-invasive, real-time surveillance system used to
detect changes in organ cell layer thickness through
quantitative monitoring of the impedance of a cell-to-microelectrode interface over time [15]. It is a real-
time, label-free, impedance-based method to study the
activities of cells including morphological changes, loco-
motion, and other behaviors of cells directed by the
cytoskeletons. When cells were added to the ECIS
Arrays and attached to the electrodes, they play the roles
as insulators and increased the impedance. As cells grow
and cover the electrodes, the current is impeded in
related with cell number, cell morphology, and cell at-
tachment. When cells are stimulated, cell function and
cell morphology will be changed and the impedance of
cell-to-microelectrode will be changed. The data gener-
ated is impedance versus time. The high frequency im-
pedance is caused by the increasing of cell numbers,
whereas the low frequency impedance indicates the in-
creasing of spaces between the cells. Previous study had
reported that ECIS can be used to identify significant,
real-time changes in organ layers caused by the invasive
activities of cultured metastatic cells [16]. Because epi-
thelial invagination is also related to the invasive activ-
ities of epithelial cells into mesenchymal cells, which
indicated that ECIS would be a good method for detect-
ing epithelial invagination in ectodermal organogenesis.
The purpose of this study is to establish a combined
bioengineered organ-ECIS model for investigating the
real time effects of fibroblast growth factor-9 (FGF-9) on
epithelial invagination in bioengineered ectodermal
organs.
In this study, we aim to establish a non-invasive, real
time model to investigate whether FGF-9 can promote
epithelial invagination for ectodermal organogenesis,
and whether there are important gene expressions
related with the development of tooth germ during this
event. We used the non-serum stem cell-separating
method [17,18] to obtain purified, non-inductive, single
epithelial and mesenchymal cells, dissected from the first
molar tooth germs of stage E14.5 (equal to cap stage of
tooth germ in development) imprinting control region
(ICR) mouse embryos (Figure 1). These cells were reag-
gregated for the epithelial invasion test in an ECIS Z8
system (Applied Biophysics, Troy, NY, USA) and sus-
tained with FGF-9 in the experimental group. This bio-
engineered organ-ECIS model provides a non-invasive,
controlled environment for the real-time investigation of
specific factors (Figure 2), avoiding mutagenesis and tis-
sue slicing and staining. Gene expression assays per-
formed at multiple time points will illuminate the
mechanisms underlying ectodermal organogenesis.Results
FGF-9 promotes tooth germ development
In preliminary experiments, we used FGF-9 cultured
with the dissociated mesenchymal cells and the dissected
Figure 1 Tooth germ dissection and dissociation. First molar tooth germ dissection from the mandibular arch of an E14.5 mouse embryo and
its dissociation into single cells using the non-serum protocol.
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results showed that FGF-9 can induce early, significant
Ameloblastin, Amelogenin and Osteocalcin expression in
mesenchymal cells cultured with FGF-9 (Additional
file 1). These findings were concurrent with the gene
expression of mesenchymal origin cells, such as odonto-
blasts, during the early stage of tooth development
[19,20]. In addition, FGF-9 can induce early expression
of the homeobox protein Msx genes Msx-1 in mesenchy-
mal cells (Additional file 1), which is consistent with
previous research [14]. The experimental group also
exhibited earlier epithelial differentiation in molar tooth
germs at 1 and 10 days in vitro (Additional file 2 and 3).
This indicated that the development of tooth germ was
promoted by FGF-9, which inspired us to detect the
role of FGF-9 in epithelial invagination.
For optimizing the effects of FGF-9 in promoting cell
proliferation, cell proliferation rate with different con-
centrations of FGF-9 were compared by MTT assay.
In this assay, yellow MTT (3-(4,5-Dimethylthiazol-2-yl)-
2,5-diphenyltetrazolium bromide, a tetrazole) is reduced
to purple formazan in the mitochondria of living cells.
The absorbance of this colored solution can be quanti-
fied by measuring at a certain wavelength (usually be-
tween 500 and 600 nm) by a spectrophotometer. The
absorption max is dependent on the solvent employed.
This reduction takes place only when mitochondrialFigure 2 The combined bioengineered organ-ECIS model for analysisreductase enzymes are active, and therefore conversion
can be directly related to the number of viable (living)
cells. The rate of tetrazolium reduction is proportional
to the rate of cell proliferation.
Subsequently, we found FGF-9 with 40 ng/ml concen-
tration was the best for promoting cell proliferation in
both dissociated epithelial cells and mesenchymal cells
(Figure 3).
MTT data suggested that FGF-9 facilitates early mes-
enchymal cell proliferation (Figure 3A). MTT data also
suggested that FGF-9 can stimulate epithelial cell prolif-
eration at 183 h (Figure 3B). Therefore, we used the
ECIS invasion test [16] to identify the role of FGF-9.
ECIS impedance change reveals FGF-9 stimulates
accelerated epithelial invagination
After dissecting the first molar tooth germ from E14.5
ICR embryos, we separated the epithelial and mesenchy-
mal layers, obtaining single cells through the non-serum
dissociation method [17,18]. We added 2 × 105 mesen-
chymal cells to each well of the ECIS 8W10E kit
(Applied Biophysics), waited 25 h for settling and reag-
gregation and obtained stable impedance (Figure 4A).
We investigated epithelial cell invasion by adding 2 × 105
epithelial cells to each well (Figure 2). The FGF-9 con-
centration was maintained at 40 ng/ml in the four
experimental wells to detect enhanced epithelial cellof epithelial invagination.
Figure 3 MTT assay. MTT assay for the in vitro culture of dissociated mesenchymal and epithelial cells to determine the optimal Fibroblast
growth factor-9 (FGF-9) concentration. (A) MTT data for mesenchymal cells (n = 4, p < 0.5): FGF-9 concentrations of 25 and 40 ng/ml were both
suitable for cell culture in the first 7 days. # : 40 ng/ml FGF-9 outperformed 25 ng/ml after 14 d of culture, (B) MTT for epithelial cells (n = 4, p < 0.5):
40 ng/ml is optimal for epithelial cell culture within the first 183 h (> 7 days). Thus, we chose 40 ng/ml FGF-9 for further experimentations.
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(1, Figure 4B). Early impedance of the FGF-9 group was
always lower than the control group, although not sig-
nificantly (Figure 4B). This suggests initial epithelial inva-
gination proceeds from the very first time point.
After 72 h (red arrow, Figure 4B), the FGF-9 group
exhibited great variation in impedance data (pink line,
Figure 4B), suggestive of significantly thinner bioengi-
neered organ layers than that of the control group.Figure 4 ECIS Assay. We chose the ECIS Z8 system, with four wells chose
The ECIS parameters include a frequency of 15,000 Hz and impedance data
and the pink line represents the FGF-9 group. The vertical (dash) line repre
and FGF-9 (40 ng/ml), it was necessary to allow mesenchymal cells to reag
2 × 105 mesenchymal cells to each well. Impedance data showed no differ
significant proliferation or death of mesenchymal cells. (B) The invasion tes
We added 2 × 105 epithelial cells to each well of the 8W10E kit. We added
medium with FGF-9 (40 ng/ml) to the FGF-9 group (pink line). The vertical
5. Stop observation at 163 h. Red arrow: significant time point (approximat
epithelial invagination starts to result in a thinner layer of bioengineered oAccording to the MTT data, FGF-9 does not jeopardize
tooth germ cell activity (Figure 3). Therefore, accelerated
epithelial invagination occurred before this time point.
This may explain significant FGF-9 expression in the
epithelium [14] and earlier differentiation of tooth germ
we observed in our preliminary in vitro organ culture
experiments (Additional file 2 and 3).
Although changing half the medium could have
affected impedance data for a short time, each groupn as the control group, and the other four wells as the FGF-9 group.
were recorded every 90 s. The black line represents the control group
sents the time of medium change. (A) Before adding epithelial cells
gregate as a stable layer in each well of the ECIS kit. We then added
ence between the two groups in the first 25 h, indicating no
t began after the addition of epithelial cells and FGF-9 (40 ng/ml).
ordinary fresh medium to the control group (black line) and fresh
(Dash) line:1. Start invasion. 2–4. Change half medium in each well.
ely 72–74 h) of impedance change in the FGF-9 group, when
rgan.
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After a 163-h observation period, there was no great
change in the control group impedance data, which
remained stable (black line, Figure 4B). We inferred that
the well of the 8W10E kit did not provide enough space
for further cell proliferation, making it pointless to con-
tinue the ECIS study beyond this time point (5,
Figure 4B). The impedance data showed that the bioen-
gineered organ increased in thickness approximately
fourfold within 7 days. During this period, electrical re-
sistance increased from <400 Ω to >1400 Ω (Figure 4B).
Although well size was limited during organ develop-
ment, we attempted to improve the culture environment
by changing the medium in the last 80 h. No further
changes in impedance occurred in either the control or
FGF-9 groups after this (Figure 4B), indicating that only
epithelial thickening occurred.FGF-9 accelerates and sustains Ameloblastin and
Amelogenin expressions
ECIS data revealed significant electric impedance
changes during the 60–84-h period (2–3, Figure 4B). We
performed mRNA detection at different time points to
determine the factors underlying ectodermal organogen-
esis. Using the same culture protocol as for previous
ECIS surveillance, we examined expression of two genes
critical to normal tooth germ development, Ameloblas-
tin and Amelogenin [21,22]. β-actin served as an internal
control for real-time 7900HT PCR.Figure 5 Real-time PCR measurement of Ameloblastin and Amelogenin
different time points in the bioengineered organ culture. Ameloblastin expr
at 72, 84 and 150 h in the FGF-9 group compared with the control group.
bioengineered organ culture. Amelogenin expression was significantly high
peaked at 72 h, coinciding with a significant change in ECIS assay (Figure 4
peak Ameloblastin expression at 60 h is followed by a peak Amelogenin exp
higher Amelogenin expression also coincides with early lower impedance d
early organ culture (Additional file 2). These results indicate that FGF-9 can
ameloblasts within the epithelium, which coincides with epithelial invagina
FGF-9 group still exhibits higher Ameloblastin and Amelogenin expressions
necessary to specify the results of the FGF-9 group.Because Ameloblastin expression precedes Amelogenin
expression [21], we established different time schedules
for their analysis: we monitored Ameloblastin expression
at 12, 60, 72, 84 and 150 h (Figure 5A), whereas we
monitored Amelogenin expression at 24, 72 and 144 h
(Figure 5B). Owing to very low Amelogenin expres-
sion, we also detected Amelogenin expression at 1 h
(Figure 5B) to determine why early impedance is lower
in the FGF-9 than the control group. Ameloblastin was
significantly elevated by FGF-9 at 12 h (Figure 5A) rela-
tive to the control group. Peak Ameloblastin expression
was evident at 60 h in the FGF-9 group (Figure 5A).
This suggests that FGF-9 accelerates early Ameloblastin
expression and induces early accelerated epithelial inva-
gination within 72–74 h. FGF-9 also accelerated and sus-
tained Ameloblastin expression during the observation
period (Figure 5A). Even at 150 h, the FGF-9 group
exhibited significantly higher Ameloblastin expression.
Combined with the comparatively lower impedance data
of the FGF-9 group (Figure 4B), the evidence suggests
that addition of FGF-9 induces early Ameloblastin
expression, some early phenotypic characteristics of ame-
loblasts existed within the epithelial layer and accelerated
epithelial invagination.
Trace Amelogenin expression was evident in the
FGF-9 group after 1 h (Figure 5B), explaining the early
lower impedance of the FGF-9 group. Consequently,
early morphological characteristics of ameloblasts oc-
curred, concurring with in vitro organ culture results
(Additional file 2). Although Amelogenin expressiongene expression. (A) Real-time PCR Ameloblastin expression at
ession peaked at 60 h. Ameloblastin expression was significantly higher
(B) Real-time PCR Amelogenin expression at different time points of the
er in the FGF-9 group compared with the control group at 1 h and
B) and due to epithelial invagination. These two graphs show that the
ression at 72 h, in agreement with previous research [21]. Significantly
ata (Figure 4B) and earlier differentiation of tooth germ evident in
initiate early phenotypic and morphological characteristics of
tion evident from the ECIS assay (Figure 4B). After invagination, the
than the control group. Because of the clear differences, no mark is
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in the control group, peaking at 72 h (Figure 5B) fol-
lowing peak Ameloblastin expression at 60 h (Figure 5A)
[21,22]. FGF-9 sustained greater Amelogenin expression
than that exhibited by the control group, even after 144 h
(Figure 5B). These results provide solid evidence that
FGF-9 accelerates epithelial invagination and early pheno-
typic and morphological characteristics of ameloblast
existed within the epithelium.Discussion
Because of the multipotency of embryonic stem cells, it
is difficult to create a non-invasive and non-inductive
environment for observing how a specific growth factor
works within ectodermal organ development. Ectoder-
mal organs are always affected by the surrounding
in vivo environment and many types of regulating fac-
tors, that might be upregulated or downregulated, or
work as feedback balancing systems.
We employed a combined bioengineered organ-ECIS
model using tooth germ cells (Figure 2), observing their
real-time development within a non-invasive, ECIS surveil-
lance system. The method also facilitated assessment of the
effect of FGF-9 on epithelial invagination over time
(Figure 4B) without tissue slicing or staining [16].
FGF-9 accelerates epithelial invagination; however, FGF-9
is only expressed in the epithelium, not in the mesenchyme.
FGF-9 is known to function in several reciprocal epithelial–
mesenchymal interactions: stimulating proliferation of mes-
enchymal cells (Figure 3A); inducing early mesenchymal ex-
pression of the crucial odontogenic genes Msx-1,
Ameloblastin and Amelogenin (Additional file 1) [14]; and
accelerating and sustaining early Ameloblastin and Amelo-
genin secretion within the tooth germ (Figure 5). Thus,
FGF-9 may drive early differentiation of the epithelial cell
layer to express phenotypic and morphological characteris-
tics of ameloblasts (Additional file 2 and 3), cause prolifera-
tion of the epithelium for invagination (Figure 3B) and
promote ectodermal organogenesis. This could explain why
FGF-9 is restricted to the epithelium and persists there [14]:
to initiate epithelial budding. Our findings also suggest that
FGF-9 could play an important role in ectodermal organ re-
generation and tissue engineering.
MTT data suggested that FGF-9 facilitates early mesen-
chymal cell proliferation (Figure 3A), possibly also increasing
endogenous FGF-10 in mesenchymal cells during prolifera-
tion. FGF-10 is known to stimulate proliferation in epithelial
cells [23], potentially creating larger tooth germs. MTT data
also suggested that FGF-9 can stimulate epithelial cell prolif-
eration at 183 h (Figure 3B). Resent research indicates that a
TGFβ-FGF9-PITX2 signaling cascade regulates cranial
neural crest cell proliferation in palatal mesenchyme during
palate formation [24]. It seems FGF-9 can regulate theproliferation and integration within mesenchymal cells in a
more specific route, which also control the interaction be-
tween ectodermal epithelium and mesenchyme. Previous re-
search [5,25] demonstrated using a bioengineered organ
culture system similar to ours that epithelial invagination oc-
curred after 1 week of in vitro culture: if dissociated epithe-
lial cells recombined with intact dissected mesenchymal
layers directly, new tooth germs formed faster than that with
reaggregated mesenchymal cell layers [5,25]. Our FGF-9
group exhibited faster mesenchymal cell integration in the
first 3–4 days than previous studies (Figure 4B) [5,6,25].
These results suggest that FGF-9 functions in assisting mes-
enchymal cells to closely re-integrated, similar to a tissue
layer. This might also explain how FGF-9 accelerates epithe-
lial invagination in murine odontogenesis: by facilitating
cross-talk and reunion between mesenchymal cells and
stimulating epithelial cell layer differentiation, creating an
ameloblast layer. Thus, FGF-9 may play a significant role in
future stem cell organ regeneration.
Some authors have suggested that Wnt-7b restricts
dental organ development to within the maxillary and
mandibular arches [26]. Ectopic epithelial Wnt-7b ex-
pression, achieved through murine retrovirus infection,
downregulates Shh expression within dental organs,
completely abrogating their development; however, sub-
sequent local Shh overexpression through beads revives
tooth germ development [26]. This suggests that FGF-9
counterbalances Wnt-7b through the Shh pathway. Pre-
vious evidence [27] demonstrated that suppressing Shh
created a similar phenotype to BMP4 overexpression
in the feather model. We propose that FGF-9 plays a
significant role in modulating the BMP-Shh ‘signal-
ling module’ regulating skin appendage morphogenesis
[27-29] by accelerating epithelial invagination. Our pre-
liminary results show that FGF-9 upregulates Msx-1
expression within a mesenchymal cell culture (Additional
file 1). Previous studies [30] showed that FGFs and
BMP4 induced both Msx1-independent and -dependent
signalling pathways in early odontogenesis. These results
suggest that FGFs and BMPs might influence the same
regulatory systems functioning in multiple developmen-
tal areas and time points. A significant, proximal–distal
pattern exists within the lower jaw epithelium of the
mouse embryo [13]: FGF-8 and FGF-9 are expressed in
the lateral molar field whereas BMP4 is expressed over
the medial incisor area. This specific pattern suggests
that FGF-8 and FGF-9 correlate with multicuspid
odontogenesis whereas BMP4 correlates with unicuspid
odontogenesis. Recent research [31] showed that both
BMPs and FGFs target the Notch signalling pathway
through the Jagged 2 (Jag2) gene, regulating tooth
morphogenesis and cytodifferentiation. However, Jag2
expression is downregulated by BMPs but upregulated
by FGFs within the dental epithelium. This suggests a
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FGFs and BMPs. If BMP overexpression suppresses Shh
expression, then FGF overexpression may promote
Shh expression, accelerating epithelial invagination. We
propose an ‘FGF-BMP balancing system’ (Figure 6), [32]
which determines the cusp number in odontogenesis
and may similarly regulate feather or skin appendage
morphogenesis. These topics are interesting issues for
further discussion and require future research.Conclusions
The bioengineered organ-ECIS model provides a novel
understanding of FGF-9 function in ectodermal organogen-
esis and insights into methods of manipulating the speed of
ectodermal organ regeneration. These results directly sup-
port the role of FGF-9 in epithelial invagination. Ours is the
first study to show that FGF-9 is, in addition to BMP-Shh
signalling [26-31,33], a major regulator of epithelial invagin-
ation during the initiation of ectodermal organogenesis, with




Stage E14.5 pregnant female ICR mice were purchased
from BioLASCO Taiwan Co., Ltd. (Taipei, Taiwan).
Mouse care and handling procedures, and experimental
protocols were approved by the National Taiwan Univer-
sity of Science Animal Care and Use Committee, andFigure 6 Proposed mechanism of FGF-BMP balancing system. In this s
epithelial invagination. No direct relationship between Sonic hedgehog (Shh
genes (such as Paired box 9) were found to support antagonistic interaction
propose an ‘FGF-BMP balancing system’ which manipulates the morphoge
previous researches and our study. “⊥” is the downregulated pathway prov
investigated further.conducted in accordance with Directive 86/609/EEC for
animal experiments.First molar tooth germ dissection and dissociation into
single cells through the non-serum protocol
Under a stereomicroscope (Leica MZ7.5; Leica Micro-
systems, Wetzlar, Germany), we microsurgically dis-
sected first molar tooth germs from the mandibular arch
of stage E14.5 (equal to cap stage of tooth germ in devel-
opment) embryos. After soaking the dissected tooth
germs in dispase (1.2–1.5 U/ml; Invitrogen, Carlsbad,
CA, USA) for 8–10 min at 4°C, we separated the epithe-
lial and mesenchymal layers using a tungsten needle.
The separated layers were stored immediately in 400 μl
Spinner modified Ca2+-free minimal essential medium
(SMEM; Sigma Chemical Co., St. Louis, MO, USA) at
4°C in a 1.5 ml microcentrifuge tube (Eppendorf,
Hamburg, Germany).
We prepared 5 ml non-serum dissociation medium
(Ling et al., 2006; Huang et al., 2009) by adding 0.01 g
protease XIV (Sigma) and 0.02 g DNase (Bioshop
Canada Inc., Burlington, CA, USA) to 5 ml SMEM and
filtering the solution with a 0.22 μm filter (Millex Syr-
inge Filter Unit; EMD Millipore Corporation, Billerica,
MA, USA). We introduced 400 μl filtered non-serum
dissociation medium into the stored cell layers. Dis-
sociation proceeded for 12–14 h at 4°C. After gentle
pipetting, we centrifuged the mixture twice at 1250
revolutions per minute (rpm) for 5 min (Kubota 2420tudy, FGF-9 upregulates Ameloblastin and Amelogenin, and speeds up
), Jagged (Jag2) and Ameloblastin has been elucidated until now. Other
s between FGFs and BMPs [32] but are not shown in this graph. We
nesis of ectodermal organs. “→” is the upregulate pathway proved by
ed by previous research. “?” is the suggested pathway need to be
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zolium bromide (MTT) crystals (Sigma) with 30–40 ml
phosphate-buffered saline, creating a 5 mg/ml solution.
We filtered this with a 0.22 mm filter (Millipore), covered
it with aluminium foil and stored it at 4°C. Next we
added 2×104 cells/well epithelial and mesenchymal cells
to a 96-well plate. We added 200 μl/well of a range of
FGF-9 (PeproTech Inc., Rocky Hill, NJ, USA) concentra-
tions—10, 25, 40 and 50 ng/ml—to mesenchymal cell
cultures. After 1, 4, 7 and 14 days’ incubation (n = 3–4),
we removed the medium, added 30 μl/well MTT solution
in darkness, then incubated for 3 h at 37°C. We removed
the MTT solution, added 50 μl/well dimethyl sulphoxide
and agitated for 10–15 min until the purple crystals dis-
solved. We performed enzyme-linked immunosorbent
assay at 570 nm optical density.
After acquisition of mesenchymal cell MTT data, we
added 200 μl/well of a range of FGF-9 concentrations—
25, 40 and 80 ng/ml-for epithelial cell culture, analysing
at 1, 4, 7 and 14 days.
Bioengineered organ culture via electric cell-substrate
impedance sensing
Owing to the limited quantity of the primary epithelial
and mesenchymal cells, we chose the ECIS Z8 (Applied
Biophysics) as an appropriate system to investigate the
real time invagination effect of the primary epithelial
cells as soon as possible. We added 2×105 mesenchymal
cells to each well of the 8W10E ECIS kit (Applied Bio-
physics). We set the frequency to 15000 Hz, collecting
impedance data every 90 seconds. We stopped ECIS
after 25 h to allow the mesenchymal cells to settle. We
then added 2×105 epithelial cells in 400 μl/well medium
to each well, maintaining the FGF-9 concentration of
the experimental group at 40 ng/ml. We maintained the
control group in 400 μl/well fresh DMEM. We restarted
ECIS impedance recording, changing half the medium at
36, 96 and 120 h (Figure 2).
7900HT real-time polymerase chain reaction gene
expression assay and statistical analysis
For 7900HT real-time PCR gene expression analysis, we
followed the ECIS assay protocol as described previ-
ously. We measured Ameloblastin expression at 12, 60,
72, 84 and 150 h and Amelogenin expression at 1, 24, 72
and 144 h. To replicate the ECIS 8W10E kit environ-
ment, we used 48-well plates for Ameloblastin andAmelogenin analysis. It was necessary to accommodate
this mass and pool data from different time points using
the real-time PCR software SDS 2.4 and RQ Manager
1.2.1 (Applied Biosystems, Foster City, CA, USA).
We purified RNA collected at different time points
using an RneasyW Mini Kit (Qiagen, Hilden, Germany)
and PureLinkW RNA Mini Kit (Invitrogen). We con-
verted mRNA to cDNA using a High Capacity RNA-to-
cDNA Kit (Invitrogen) and a T1 Plus Thermocycler
(Montreal Biotech Inc., Dorval, PQ, Canada). We used
the TaqManW Gene Expression Assay for Ameloblastin
(Mm00711644_g1; Invitrogen), Amelogenin (Mm00477486_m1;
Invitrogen) and the internal control β-actin (Mm01205647_g1;
Invitrogen) in the 7900HT Fast Real-Time PCR System
(Invitrogen). After TaqManW Gene Expression Master
Mix (Invitrogen), we added the cDNA to the reaction
plate and centrifuged the mixture (3500 rpm, 4°C, 5 sec-
onds) to spin down the contents of each well. Then, we
performed 7900HT PCR to determine relative gene
expressions over time.
We marked at least four samples for each time point
from the control and FGF-9 groups. We divided the
cDNA from each sample into three wells to determine
the expression of each gene in triplicate assay in a 96-
well reaction plate. After 7900HT PCR, we pooled the
data from SDS 2.4 into RQ Manager 1.2.1 to determine
the average relative quantity of each sample, then used a
base-10 logarithm to determine gene expressions. Next,
we calculated the standard deviation of both groups at
each time point and used the paired t-test for statistical
analysis. We entered this data into SigmaPlot 10.0
(Systat Software Inc., San Jose, CA, USA) to construct
gene expression plots for Ameloblastin and Amelogenin
over time.Additional files
Additional file 1: Preliminary experiment: FGF-9 upregulates
Ameloblastin and Amelogenin in cultured mesenchymal cells.
Mesenchymal cells were cultured in vitro and FGF-9 (25 ng/ml) was
added to the experimental group. FGF-9 significantly upregulated
Ameloblastin and Amelogenin expression [19,20]. The homeobox protein
Msx genes Msx-1 and Msx-2 (although expressed at low levels), and
Osteocalcin were also upregulated after initial contact with FGF-9. Msx-1
and Msx-2 are critical to tooth germ development. Upregulation of Msx-1
and weak expression of Msx-2 evident in this study agree with previous
research [14]. Osteocalcin was upregulated by FGF-9 in the first week and
high expression was sustained compared with the control group, only
diminishing temporarily at the 14th day. These results highlight the
importance of FGF-9 in ectodermal organogenesis. (A) Electrophoresis of
Ameloblastin, Amelogenin, Msx-1, Msx-2, Osteocalcin, and β-actin
expression. We used β-actin as internal control. (B) Ameloblastin
expression of mesenchymal cell cultured with FGF-9 in vitro, (C)
Amelogenin expression, (D) Msx-1 expression, (E) Msx-2 expression, and (F)
Osteocalcin expression. (G) Internal control of the preliminary experiment:
β-actin expression. (n = 3, p < 0.5) CD: control group. FD: FGF-9 group.
Additional file 2: Haematoxylin and eosin staining of ectodermal
organ culture. Day-1. (n=4) (A) and (B) control group Day 1. (C) and (D)
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http://www.biosignaling.com/content/10/1/34FGF-9 group Day 1. Tooth germs cultured with FGF-9 demonstrated
more differentiated than that in the control group. In this study, eight
embryonic tooth germs were cultured, 4 for experimental group cultured
with FGF-9, 4 for control group cultured without FGF-9. Some
mineralized epithelium and morphological characteristics of ameloblasts
were found in the experimental group with FGF-9, (C) and (D). (A) and
(C): 200×; Bar = 12.5 μm. (B) and (D): 400×; Bar = 25 μm; 1: epithelium. 2:
mesenchyme.
Additional file 3: Haematoxyliin and eosin staining of ectodermal
organ culture. Day 10. (n=4) Eight embryonic tooth germs were
cultured, 4 for experimental group cultured with FGF-9, 4 for control
group cultured without FGF-9. (A) control group Day 10. Only simple
epithelium and mesenchyme in the tooth germ was found. 1: epithelium.
2: mesenchyme. (B) FGF-9 group Day 10. The FGF-9 group showed a more
complex tooth germ structure after organ culture in vitro for 10 days. 3:
some morphological characteristic of ameloblasts. 4: some morphological
characteristic of odontoblasts. 5: mesenchyme. Bar = 25 μm. Magnification
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